A new anti-cancer drug delivery system which allows more targeted
treatment and helps avoid the unsafe and unpleasant side effects of
chemotherapy is due to enter clinical trials in Europe and the US
for use with anti-cancer drug...
MedImmune's latest version of their inhalable flu vaccine, FluMist,
has been approved by the US Food and Drug Administration (FDA). The
new formulation can now be stored in a refrigerator rather than
frozen, which proved a major...
US researchers have been awarded a patent for their new
manufacturing technology which enables the quick and cheap
production of nanoparticles used to formulate and deliver drugs -
good news for NanoMed who has an exclusive licence...
The US Food and Drug Administration (FDA) has approved Janssen's
new drug Invega (paliperidone); the first new prescription drug for
the treatment of schizophrenia since 2003.
US researchers have combined cancer drug-carrying liposomes and
heat, which accelerates drug release and delivers 30 times more
drug to tumours, as visualised in vivo using magnetic
resonance imaging (MRI)
Solid oral dose product specialist Almac Pharma has announced it
has expanded its formulation facilities located at its UK
headquarters to provide a wider range of services to pharma and
biotech companies.
Icelandic pharmaceutical Actavis has snapped up an Indian
manufacturing plant in a move to take advantage of lower
manufacturing costs for exports to the US and Europe.
Specialty pharmaceutical company CyDex has been boosted by the news
that an intramuscular injection formulation of schizophrenia drug
Abilify, which makes use of its Captisol solubility technology has
been launched in the USA.
Crucell yesterday announced it had received the first orders from
US-headquartered Wyeth Biotech. The order represents the first move
following the finalisation of the contract manufacturing agreement
between the two companies at...
Innovative, non-invasive new ways of delivering insulin are poised
to transform diabetes management, despite concerns about their
safety and efficacy, according to new research.
Researchers have discovered that using nanotechnology could help
reduce fatalities from drug overdoses, as nanoparticles can act as
potential antidotes.
Medicated chewing gum company Fertin Pharma has announced a
collaboration with the US Army Dental Research and Trauma
Detachment (USADRT) on the first antimicrobial chewing gum to lower
incidences of disease and non-battle related...
Solvay has contracted Novasep to provide synthesis of two active
pharmaceutical ingredients, following Novasep's decision to combine
synthesis and processing expertise.
Pharma company Shire has agreed with European regulators on
labelling information for its ulcerative colitis drug Mezavant, a
further step in the firm's ambition to capture more of the $1.6bn
(€1.2bn) mesalazine market through...
Drug delivery company MonoSolRx has announced it has received a
$38m (€29m) funding from an investment group, illustrating the
appeal of the company's dissolving film technology.
Dr Reddy's Laboratories has started first clinical trials of a
"four-in-one" polypill clinical trial, which could revolutionise
the cardiovascular drugs market.
Vion Pharmaceuticals has awarded a manufacturing agreement with
Ohio based contract manufacturers Ben Venue Laboratories to produce
its lead anticancer drug, Cloretazine (VNP40101M).
Roche has invested $20m in a new technology that has the potential
to dramatically enhance the delivery of subcutaneous drugs by
acting like a 'molecular machete'.
Almost 130 jobs will be lost at BASF's Minden site as the company
succumbs to growing pressure from the Asian generic active
pharmaceutical ingredient (API) market.
US researchers have developed a novel delivery vehicle for siRNA,
an up-and-coming technology for switching off genes in the body
that could accelerate its use in drug development.
A new 'glass' making technique that improves stability and
durability could lead to novel coatings and improvements in drug
delivery, according to researchers at the University of
Wisconsin-Madison and the National Institute...
Dutch researchers have developed a new way of making a Parkinson's
disease drug using an inexpensive ionic liquid method that could
yield cost savings of €11.3 million per annum.
Nastech missed out on a $15m (€11m) milestone payment after having
to delay the development of its new nasal spray for the treatment
of osteoporosis because of the need of an additional clinical
trial.
AAIPharma has announced it has signed a contract manufacturing
agreement with Mallinckrodt Pharmaceuticals Outsourcing which aims
to provide a "one-stop drug development solution" for drug makers.
Rockwood Holdings announced last week that it has reached an
agreement to sell its subsidiary Groupe Novasep to a consortium of
buyers in a transaction valued at €425m.
Canadian pharma manufacturer Bioxel has announced it has received
several orders for its paclitaxel product - a taxane-based drug
effective to treat cancer - from two European customers
representing a total of CAD$630,000 (€420,000).
British chemical products and technologies firm Reaxa has launched
a new encapsulated catalyst for market trials. Platinum EnCat is a
platinum nanoparticle catalyst encapsulated within polymer beads,
intended for the hydrogenation...
Major drug companies across the US have scrambled to reformulate
their over-the-counter cold medications in time for a new law that
came in to effect in September, however, there are claims that the
new formulations are a flop.
Granules India and Biocause have signed an agreement to create a 50
: 50 joint venture entity to manufacture and sell pharmaceutical
APIs (Active Pharmaceutical Ingredients), starting with Ibuprofen.
Scientists have discovered a new nanoparticule-based drug delivery
system to treat brain cancer that it claims could revolutionise
currently used chemotherapeutic treatments for this devastating
type of cancer.
Canadian pharma manufacturer Bioxel has announced the filing of a
second international patent application to secure the synthesis of
paclitaxel and decetaxel - two taxane-based drugs effective against
cancer.
DSM Venturing, the investment arm of the Dutch chemical giant, has
announced it has snapped a 10 per cent share in pharma materials
provider Micromuscle.
Actelion has announced it is acquiring biopharmaceutical company
CoTherix for $420m (€328m) with the objective of taking over and
increasing the distribution of Ventavis, the only approved inhaled
therapy for the treatment of Pulmonary...
Vectura and Innovata have announced they are merging in a deal
worth £128.8m with the objective of becoming UK's number one in the
pulmonary drug development sector.
Australia's pSivida said that an undisclosed US firm is now
evaluating its novel BioSilicon technology with the aim of
developing new transdermal drug delivery systems.
Dor BioPharma has announced it has made progress with the
formulation of RiVax, a new drug that could be the world's first
vaccine for the deadly ricin toxin.
India's Aurobindo Pharma has decided to cut loose its bleeding
Chinese pharma subsidiary - while still holding on to its
ingredients making operation - and instead focus on a new
investment in India.
International drug firms are increasingly turning to Taiwan for the
low-cost made-to-order processing of active pharmaceutical
ingredients (APIs), according to the Taiwan External Trade
Development Council (TAITRA).
Researchers in Denmark have discovered a new drug delivery method
based on sugar nanocapsules that could be a breakthrough to treat
cancer, viral diseases and hereditary disorders.
Oxford Biomedica has made available preclinical efficacy data,
which suggests that gene-based product could have significant
efficacy for those suffering from Parkinson's disease when compared
to current treatment methods.